English

NUTEX HEALTH INC.

EDGAR

CLNH Quarterly report (10-Q) · filed 2026-08-06

Annual consolidated revenue for 2025: about USD 875.3M, using the latest reported figures. The previous period, 2024, was about USD 479.9M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

211 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 210752000 USD Source

Operating margin

57.75%

2026 Q2 · %

Exact inputs and evidence

Operating Income: 121718000 USD Source
Revenue: 210752000 USD Source

Operating cash flow

34.2 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 109718000 USD Source
Operating Cash Flow: 75518000 USD Source

Free cash flow

31.7 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 109718000 USD Source
Operating Cash Flow: 75518000 USD Source
Capital Expenditure: 3741000 USD Source
Capital Expenditure: 1201000 USD Source

Cash and cash equivalents: 205 million USD 2026-06-30 Source
Exact value

205208000 USD
Long-term debt including current maturities: 24.7 million USD 2022-09-30 Source
Exact value

24690473 USD
Shares outstanding: 6.84 million shares 2026-06-30 Source
Exact value

6843785 shares

Reported share-count change

3.77% · 249 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

6595109 shares · 2025-06-30· Source
6843785 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

847 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 267804000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 875257000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 723578000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 216485000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 210752000 USD · 2026-04-01 – 2026-06-30 Source

Net income

180 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: 55435000 USD · 2025-07-01 – 2025-09-30 Source
Net income: 70789000 USD · 2025-01-01 – 2025-12-31 Source
Net income: 58955000 USD · 2025-01-01 – 2025-09-30 Source
Net income: 46807000 USD · 2026-01-01 – 2026-03-31 Source
Net income: 65842000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

280 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: 177736000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 78222000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: 248125000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: 177736000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 75518000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: 109718000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: 75518000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

5.45 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 1117000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 815000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 2526000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 1117000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 1201000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 3741000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 1201000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

274 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: 177736000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 78222000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: 248125000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: 177736000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 75518000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: 109718000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: 75518000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 1117000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 815000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 2526000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 1117000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 1201000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 3741000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 1201000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-06.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 8 of 11 periods available· newest 2025-12-31
Total assets: 10 of 11 periods available· newest 2025-12-31
Total liabilities: 10 of 11 periods available· newest 2025-12-31
Current assets: 10 of 11 periods available· newest 2025-12-31
Current liabilities: 10 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 4 of 11 periods available· newest 2021-12-31
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+82.4%

Prior period

USD 479.95 million

2024-01-01 – 2024-12-31
Current period

USD 875.26 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

875257000 − 479949000 = 395308000 USD

479949000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
875257000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NUTEX HEALTH INC. · 2025-12-31 NUTEX HEALTH INC. (edgar:1479681) Year-over-year change in Revenue: 395308000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 875257000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#2167226 Filing: 000162828026015168 Input fundies:Revenue: 479949000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#2168069 Filing: 000162828026015168
The citation records this snapshot. The page link may show a newer release later.
Net income
+35.9%

Prior period

USD 52.1 million

2024-01-01 – 2024-12-31
Current period

USD 70.79 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

70789000 − 52097000 = 18692000 USD

52097000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
70789000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NUTEX HEALTH INC. · 2025-12-31 NUTEX HEALTH INC. (edgar:1479681) Year-over-year change in Net income: 18692000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 70789000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1080793 Filing: 000162828026015168 Input fundies:NetIncome: 52097000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1081561 Filing: 000162828026015168
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+971.7%

Prior period

USD 23.15 million

2024-01-01 – 2024-12-31
Current period

USD 248.13 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

248125000 − 23153000 = 224972000 USD

23153000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
248125000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NUTEX HEALTH INC. · 2025-12-31 NUTEX HEALTH INC. (edgar:1479681) Year-over-year change in Operating cash flow: 224972000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 248125000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1284537 Filing: 000162828026015168 Input fundies:OperatingCashFlow: 23153000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1285197 Filing: 000162828026015168
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+9.6%

Prior period

USD 2.3 million

2024-01-01 – 2024-12-31
Current period

USD 2.53 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

2526000 − 2304000 = 222000 USD

2304000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
2526000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · NUTEX HEALTH INC. · 2025-12-31 NUTEX HEALTH INC. (edgar:1479681) Year-over-year change in Capital expenditure: 222000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 2526000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1287994 Filing: 000162828026015168 Input fundies:CapitalExpenditure: 2304000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1288584 Filing: 000162828026015168
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 875.26 million 100% of revenue
Cost of revenue USD 430.98 million 49% of revenue
Operating expenses USD 168.66 million 19% of revenue
Operating income USD 275.63 million 31% of revenue
Tax, interest and other Derived USD 204.84 million 23% of revenue
Net income USD 70.79 million 8.1% of revenue

Cash

Operating cash flow USD 248.13 million 28% of revenue
Capital expenditure USD 2.53 million 0.3% of revenue
Free cash flow Derived USD 245.6 million 28% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Not shown: operating income or net income is not reported.
2017 Operating loss: operating costs were 24,674% of revenue.
2018 Operating loss: operating costs were 161% of revenue.
2019 Operating loss: operating costs were 605% of revenue.
2020 Net loss: net income was −356% of revenue.
2021 Operating loss: operating costs were 148% of revenue.
2022 Operating loss: operating costs were 285% of revenue.
2023 Operating loss: operating costs were 113% of revenue.
2024 11%16%73%
2025 23%69%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	0	448595 Derived	-448595	6983646 Derived	-7432241	Unavailable	Source 2016-01-01 – 2016-12-31: 0 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -448595 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -7432241 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -274223 USD Inspect Operating Cash Flow Open source
2017 2017-01-01 – 2017-12-31	23166	5716086 Derived	-5692920	-6274982 Derived	582062	Unavailable	Source 2017-01-01 – 2017-12-31: 23166 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -5692920 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: 582062 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -714623 USD Inspect Operating Cash Flow Open source
2018 2018-01-01 – 2018-12-31	1366996	2207394 Derived	-840398	109731 Derived	-950129	-480049 Derived	Source 2018-01-01 – 2018-12-31: 1366996 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -840398 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -950129 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -480049 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 0 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	1366419	8264267 Derived	-6897848	218672 Derived	-7116520	-4124580 Derived	Source 2019-01-01 – 2019-12-31: 1366419 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -6897848 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -7116520 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -4040578 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 84002 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	1585952	212632 Derived	1373320	7023487 Derived	-5650167	-1475075 Derived	Source 2020-01-01 – 2020-12-31: 1585952 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 1373320 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -5650167 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -1475075 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 0 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	18793783	27811858 Derived	-9018075	4650549 Derived	-13668624	Unavailable	Source 2021-01-01 – 2021-12-31: 18793783 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -9018075 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -13668624 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -6703530 USD Inspect Operating Cash Flow Open source
2022 2022-01-01 – 2022-12-31	219294306	625893460 Derived	-406599154	18181292 Derived	-424780446	35974694 Derived	Source 2022-01-01 – 2022-12-31: 219294306 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -406599154 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -424780446 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: 50607108 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 14632414 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	247646000	279420000 Derived	-31774000	14013000 Derived	-45787000	-8240000 Derived	Source 2023-01-01 – 2023-12-31: 247646000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -31774000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -45787000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 1257000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 9497000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	479949000	349251000 Derived	130698000	78601000 Derived	52097000	20849000 Derived	Source 2024-01-01 – 2024-12-31: 479949000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: 130698000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: 52097000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: 23153000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 2304000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	875257000	599632000 Derived	275625000	204836000 Derived	70789000	245599000 Derived	Source 2025-01-01 – 2025-12-31: 875257000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: 275625000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: 70789000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: 248125000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 2526000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 875.3M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	0	Revenue: 0 Open source
20172017-12-31	Revenue	23166	Revenue: 23166 Open source
20182018-12-31	Revenue	1366996	Revenue: 1366996 Open source
20192019-12-31	Revenue	1366419	Revenue: 1366419 Open source
20202020-12-31	Revenue	1585952	Revenue: 1585952 Open source
20212021-12-31	Revenue	18793783	Revenue: 18793783 Open source
20222022-12-31	Revenue	219294306	Revenue: 219294306 Open source
20232023-12-31	Revenue	247646000	Revenue: 247646000 Open source
20242024-12-31	Revenue	479949000	Revenue: 479949000 Open source
20252025-12-31	Revenue	875257000	Revenue: 875257000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

82.4% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 474679 Open source
20172017-12-31	Year over year	No prior comparable period	Revenue: 23166 Open source Revenue: 0 Open source
20182018-12-31	Year over year	5,800.9%	Revenue: 1366996 Open source Revenue: 23166 Open source
20192019-12-31	Year over year	-0%	Revenue: 1366419 Open source Revenue: 1366996 Open source
20202020-12-31	Year over year	16.1%	Revenue: 1585952 Open source Revenue: 1366419 Open source
20212021-12-31	Year over year	1,085%	Revenue: 18793783 Open source Revenue: 1585952 Open source
20222022-12-31	Year over year	1,066.8%	Revenue: 219294306 Open source Revenue: 18793783 Open source
20232023-12-31	Year over year	12.9%	Revenue: 247646000 Open source Revenue: 219294306 Open source
20242024-12-31	Year over year	93.8%	Revenue: 479949000 Open source Revenue: 247646000 Open source
20252025-12-31	Year over year	82.4%	Revenue: 875257000 Open source Revenue: 479949000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 31.5% 2025

Net margin 8.1% 2025

Free cash flow margin 28.1% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	Not reported	Operating Income: -448595 Open source Revenue: 0 Open source
20172017-12-31	Operating margin	-24,574.5%	Operating Income: -5692920 Open source Revenue: 23166 Open source
20182018-12-31	Operating margin	-61.5%	Operating Income: -840398 Open source Revenue: 1366996 Open source
20192019-12-31	Operating margin	-504.8%	Operating Income: -6897848 Open source Revenue: 1366419 Open source
20202020-12-31	Operating margin	86.6%	Operating Income: 1373320 Open source Revenue: 1585952 Open source
20212021-12-31	Operating margin	-48%	Operating Income: -9018075 Open source Revenue: 18793783 Open source
20222022-12-31	Operating margin	-185.4%	Operating Income: -406599154 Open source Revenue: 219294306 Open source
20232023-12-31	Operating margin	-12.8%	Operating Income: -31774000 Open source Revenue: 247646000 Open source
20242024-12-31	Operating margin	27.2%	Operating Income: 130698000 Open source Revenue: 479949000 Open source
20252025-12-31	Operating margin	31.5%	Operating Income: 275625000 Open source Revenue: 875257000 Open source
20162016-12-31	Net margin	Not reported	Net Income: -7432241 Open source Revenue: 0 Open source
20172017-12-31	Net margin	2,512.6%	Net Income: 582062 Open source Revenue: 23166 Open source
20182018-12-31	Net margin	-69.5%	Net Income: -950129 Open source Revenue: 1366996 Open source
20192019-12-31	Net margin	-520.8%	Net Income: -7116520 Open source Revenue: 1366419 Open source
20202020-12-31	Net margin	-356.3%	Net Income: -5650167 Open source Revenue: 1585952 Open source
20212021-12-31	Net margin	-72.7%	Net Income: -13668624 Open source Revenue: 18793783 Open source
20222022-12-31	Net margin	-193.7%	Net Income: -424780446 Open source Revenue: 219294306 Open source
20232023-12-31	Net margin	-18.5%	Net Income: -45787000 Open source Revenue: 247646000 Open source
20242024-12-31	Net margin	10.9%	Net Income: 52097000 Open source Revenue: 479949000 Open source
20252025-12-31	Net margin	8.1%	Net Income: 70789000 Open source Revenue: 875257000 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -274223 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 23166 Open source Operating Cash Flow: -714623 Open source
20182018-12-31	Free cash flow margin	-35.1%	Revenue: 1366996 Open source Operating Cash Flow: -480049 Open source Capital Expenditure: 0 Open source
20192019-12-31	Free cash flow margin	-301.9%	Revenue: 1366419 Open source Operating Cash Flow: -4040578 Open source Capital Expenditure: 84002 Open source
20202020-12-31	Free cash flow margin	-93%	Revenue: 1585952 Open source Operating Cash Flow: -1475075 Open source Capital Expenditure: 0 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 18793783 Open source Operating Cash Flow: -6703530 Open source
20222022-12-31	Free cash flow margin	16.4%	Revenue: 219294306 Open source Operating Cash Flow: 50607108 Open source Capital Expenditure: 14632414 Open source
20232023-12-31	Free cash flow margin	-3.3%	Revenue: 247646000 Open source Operating Cash Flow: 1257000 Open source Capital Expenditure: 9497000 Open source
20242024-12-31	Free cash flow margin	4.3%	Revenue: 479949000 Open source Operating Cash Flow: 23153000 Open source Capital Expenditure: 2304000 Open source
20252025-12-31	Free cash flow margin	28.1%	Revenue: 875257000 Open source Operating Cash Flow: 248125000 Open source Capital Expenditure: 2526000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 248.1M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-274223	Operating Cash Flow: -274223 Open source
20172017-12-31	Operating cash flow	-714623	Operating Cash Flow: -714623 Open source
20182018-12-31	Operating cash flow	-480049	Operating Cash Flow: -480049 Open source
20192019-12-31	Operating cash flow	-4040578	Operating Cash Flow: -4040578 Open source
20202020-12-31	Operating cash flow	-1475075	Operating Cash Flow: -1475075 Open source
20212021-12-31	Operating cash flow	-6703530	Operating Cash Flow: -6703530 Open source
20222022-12-31	Operating cash flow	50607108	Operating Cash Flow: 50607108 Open source
20232023-12-31	Operating cash flow	1257000	Operating Cash Flow: 1257000 Open source
20242024-12-31	Operating cash flow	23153000	Operating Cash Flow: 23153000 Open source
20252025-12-31	Operating cash flow	248125000	Operating Cash Flow: 248125000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 245.6M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	Unavailable	Operating Cash Flow: -274223 Open source
20172017-12-31	Free cash flow	Unavailable	Operating Cash Flow: -714623 Open source
20182018-12-31	Free cash flow	-480049	Operating Cash Flow: -480049 Open source Capital Expenditure: 0 Open source
20192019-12-31	Free cash flow	-4124580	Operating Cash Flow: -4040578 Open source Capital Expenditure: 84002 Open source
20202020-12-31	Free cash flow	-1475075	Operating Cash Flow: -1475075 Open source Capital Expenditure: 0 Open source
20212021-12-31	Free cash flow	Unavailable	Operating Cash Flow: -6703530 Open source
20222022-12-31	Free cash flow	35974694	Operating Cash Flow: 50607108 Open source Capital Expenditure: 14632414 Open source
20232023-12-31	Free cash flow	-8240000	Operating Cash Flow: 1257000 Open source Capital Expenditure: 9497000 Open source
20242024-12-31	Free cash flow	20849000	Operating Cash Flow: 23153000 Open source Capital Expenditure: 2304000 Open source
20252025-12-31	Free cash flow	245599000	Operating Cash Flow: 248125000 Open source Capital Expenditure: 2526000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

53.9% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	1,249%	Total Liabilities: 6380260 Open source Total Assets: 510835 Open source
20172017-12-31	Liabilities / assets	28.8%	Total Liabilities: 959780 Open source Total Assets: 3328755 Open source
20182018-12-31	Liabilities / assets	433.2%	Total Liabilities: 1946781 Open source Total Assets: 449428 Open source
20192019-12-31	Liabilities / assets	72.2%	Total Liabilities: 4834071 Open source Total Assets: 6692504 Open source
20202020-12-31	Liabilities / assets	767.5%	Total Liabilities: 1303652 Open source Total Assets: 169857 Open source
20212021-12-31	Liabilities / assets	51.5%	Total Liabilities: 203069033 Open source Total Assets: 394650043 Open source
2022-12-31	Liabilities / assets	Not reported	No source recorded
20232023-12-31	Liabilities / assets	80.1%	Total Liabilities: 319139391 Open source Total Assets: 398245497 Open source
20242024-12-31	Liabilities / assets	71.2%	Total Liabilities: 466787000 Open source Total Assets: 655320000 Open source
20252025-12-31	Liabilities / assets	53.9%	Total Liabilities: 495088000 Open source Total Assets: 918525000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.41× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	0.08×	Current Assets: 507932 Open source Current Liabilities: 6380260 Open source
20172017-12-31	Current assets / current liabilities	0.06×	Current Assets: 55080 Open source Current Liabilities: 959780 Open source
20182018-12-31	Current assets / current liabilities	0.29×	Current Assets: 305417 Open source Current Liabilities: 1044061 Open source
20192019-12-31	Current assets / current liabilities	0.27×	Current Assets: 1243352 Open source Current Liabilities: 4610453 Open source
20202020-12-31	Current assets / current liabilities	0.14×	Current Assets: 157056 Open source Current Liabilities: 1153652 Open source
20212021-12-31	Current assets / current liabilities	4.09×	Current Assets: 154015179 Open source Current Liabilities: 37690959 Open source
2022-12-31	Current assets / current liabilities	Not reported	No source recorded
20232023-12-31	Current assets / current liabilities	1.56×	Current Assets: 90848403 Open source Current Liabilities: 58313052 Open source
20242024-12-31	Current assets / current liabilities	1.9×	Current Assets: 292479000 Open source Current Liabilities: 154225000 Open source
20252025-12-31	Current assets / current liabilities	3.41×	Current Assets: 538811000 Open source Current Liabilities: 157911000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 7.43 million Exact value Exact value: -7432241 USD 2016-01-01 – 2016-12-31: -7432241 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTEX HEALTH INC. · 2016-12-31 NUTEX HEALTH INC. (edgar:1479681) Net Income: -7432241 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7432241 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706218000127/igmb-20171231.xml#503136 Filing: 000160706218000127 The citation records this snapshot. The page link may show a newer release later.	−USD 274,223 Exact value Exact value: -274223 USD 2016-01-01 – 2016-12-31: -274223 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTEX HEALTH INC. · 2016-12-31 NUTEX HEALTH INC. (edgar:1479681) Operating Cash Flow: -274223 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -274223 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706218000127/igmb-20171231.xml#523354 Filing: 000160706218000127 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	USD 582,062 Exact value Exact value: 582062 USD 2017-01-01 – 2017-12-31: 582062 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTEX HEALTH INC. · 2017-12-31 NUTEX HEALTH INC. (edgar:1479681) Net Income: 582062 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: 582062 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706219000163/igmb-20181231.xml#119990 Filing: 000160706219000163 The citation records this snapshot. The page link may show a newer release later.	−USD 714,623 Exact value Exact value: -714623 USD 2017-01-01 – 2017-12-31: -714623 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTEX HEALTH INC. · 2017-12-31 NUTEX HEALTH INC. (edgar:1479681) Operating Cash Flow: -714623 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -714623 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706219000163/igmb-20181231.xml#128296 Filing: 000160706219000163 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2018-01-01 – 2018-12-31	−USD 950,129 Exact value Exact value: -950129 USD 2018-01-01 – 2018-12-31: -950129 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTEX HEALTH INC. · 2018-12-31 NUTEX HEALTH INC. (edgar:1479681) Net Income: -950129 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -950129 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706220000125/clnh-20191231.xml#596462 Filing: 000160706220000125 The citation records this snapshot. The page link may show a newer release later.	−USD 480,049 Exact value Exact value: -480049 USD 2018-01-01 – 2018-12-31: -480049 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTEX HEALTH INC. · 2018-12-31 NUTEX HEALTH INC. (edgar:1479681) Operating Cash Flow: -480049 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -480049 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706220000125/clnh-20191231.xml#600060 Filing: 000160706220000125 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2018-01-01 – 2018-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTEX HEALTH INC. · 2018-12-31 NUTEX HEALTH INC. (edgar:1479681) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706220000125/clnh-20191231.xml#600405 Filing: 000160706220000125 The citation records this snapshot. The page link may show a newer release later.	−USD 480,049 Calculation and evidence -480049 − 0 USD Exact free cash flow: -480049 USD 2018-01-01 – 2018-12-31: -480049 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTEX HEALTH INC. · 2018-12-31 NUTEX HEALTH INC. (edgar:1479681) Free cash flow: -480049 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -480049 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706220000125/clnh-20191231.xml#600060 Filing: 000160706220000125 Input fundies:CapitalExpenditure: 0 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706220000125/clnh-20191231.xml#600405 Filing: 000160706220000125 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 7.12 million Exact value Exact value: -7116520 USD 2019-01-01 – 2019-12-31: -7116520 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTEX HEALTH INC. · 2019-12-31 NUTEX HEALTH INC. (edgar:1479681) Net Income: -7116520 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7116520 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706221000074/clnh-20201231.xml#588148 Filing: 000160706221000074 The citation records this snapshot. The page link may show a newer release later.	−USD 4.04 million Exact value Exact value: -4040578 USD 2019-01-01 – 2019-12-31: -4040578 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTEX HEALTH INC. · 2019-12-31 NUTEX HEALTH INC. (edgar:1479681) Operating Cash Flow: -4040578 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4040578 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706221000074/clnh-20201231.xml#582663 Filing: 000160706221000074 The citation records this snapshot. The page link may show a newer release later.	USD 84,002 Exact value Exact value: 84002 USD 2019-01-01 – 2019-12-31: 84002 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTEX HEALTH INC. · 2019-12-31 NUTEX HEALTH INC. (edgar:1479681) Capital Expenditure: 84002 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 84002 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706221000074/clnh-20201231.xml#582317 Filing: 000160706221000074 The citation records this snapshot. The page link may show a newer release later.	−USD 4.12 million Calculation and evidence -4040578 − 84002 USD Exact free cash flow: -4124580 USD 2019-01-01 – 2019-12-31: -4040578 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 84002 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTEX HEALTH INC. · 2019-12-31 NUTEX HEALTH INC. (edgar:1479681) Free cash flow: -4124580 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4040578 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706221000074/clnh-20201231.xml#582663 Filing: 000160706221000074 Input fundies:CapitalExpenditure: 84002 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706221000074/clnh-20201231.xml#582317 Filing: 000160706221000074 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 5.65 million Exact value Exact value: -5650167 USD 2020-01-01 – 2020-12-31: -5650167 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTEX HEALTH INC. · 2020-12-31 NUTEX HEALTH INC. (edgar:1479681) Net Income: -5650167 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5650167 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706222000229/clnh123121form10k.htm#840258 Filing: 000160706222000229 The citation records this snapshot. The page link may show a newer release later.	−USD 1.48 million Exact value Exact value: -1475075 USD 2020-01-01 – 2020-12-31: -1475075 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTEX HEALTH INC. · 2020-12-31 NUTEX HEALTH INC. (edgar:1479681) Operating Cash Flow: -1475075 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1475075 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706222000229/clnh123121form10k.htm#935892 Filing: 000160706222000229 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2020-01-01 – 2020-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTEX HEALTH INC. · 2020-12-31 NUTEX HEALTH INC. (edgar:1479681) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706221000074/clnh-20201231.xml#582160 Filing: 000160706221000074 The citation records this snapshot. The page link may show a newer release later.	−USD 1.48 million Calculation and evidence -1475075 − 0 USD Exact free cash flow: -1475075 USD 2020-01-01 – 2020-12-31: -1475075 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTEX HEALTH INC. · 2020-12-31 NUTEX HEALTH INC. (edgar:1479681) Free cash flow: -1475075 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1475075 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706222000229/clnh123121form10k.htm#935892 Filing: 000160706222000229 Input fundies:CapitalExpenditure: 0 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706221000074/clnh-20201231.xml#582160 Filing: 000160706221000074 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 13.67 million Exact value Exact value: -13668624 USD 2021-01-01 – 2021-12-31: -13668624 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTEX HEALTH INC. · 2021-12-31 NUTEX HEALTH INC. (edgar:1479681) Net Income: -13668624 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13668624 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706222000229/clnh123121form10k.htm#839952 Filing: 000160706222000229 The citation records this snapshot. The page link may show a newer release later.	−USD 6.7 million Exact value Exact value: -6703530 USD 2021-01-01 – 2021-12-31: -6703530 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTEX HEALTH INC. · 2021-12-31 NUTEX HEALTH INC. (edgar:1479681) Operating Cash Flow: -6703530 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6703530 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000160706222000229/clnh123121form10k.htm#935445 Filing: 000160706222000229 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	−USD 424.78 million Exact value Exact value: -424780446 USD 2022-01-01 – 2022-12-31: -424780446 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTEX HEALTH INC. · 2022-12-31 NUTEX HEALTH INC. (edgar:1479681) Net Income: -424780446 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -424780446 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828025052895/nutx-20241231.htm#1296615 Filing: 000162828025052895 The citation records this snapshot. The page link may show a newer release later.	USD 50.61 million Exact value Exact value: 50607108 USD 2022-01-01 – 2022-12-31: 50607108 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTEX HEALTH INC. · 2022-12-31 NUTEX HEALTH INC. (edgar:1479681) Operating Cash Flow: 50607108 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 50607108 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828025052895/nutx-20241231.htm#1191003 Filing: 000162828025052895 The citation records this snapshot. The page link may show a newer release later.	USD 14.63 million Exact value Exact value: 14632414 USD 2022-01-01 – 2022-12-31: 14632414 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTEX HEALTH INC. · 2022-12-31 NUTEX HEALTH INC. (edgar:1479681) Capital Expenditure: 14632414 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 14632414 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828025052895/nutx-20241231.htm#1194139 Filing: 000162828025052895 The citation records this snapshot. The page link may show a newer release later.	USD 35.97 million Calculation and evidence 50607108 − 14632414 USD Exact free cash flow: 35974694 USD 2022-01-01 – 2022-12-31: 50607108 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 14632414 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTEX HEALTH INC. · 2022-12-31 NUTEX HEALTH INC. (edgar:1479681) Free cash flow: 35974694 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 50607108 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828025052895/nutx-20241231.htm#1191003 Filing: 000162828025052895 Input fundies:CapitalExpenditure: 14632414 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828025052895/nutx-20241231.htm#1194139 Filing: 000162828025052895 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 45.79 million Exact value Exact value: -45787000 USD 2023-01-01 – 2023-12-31: -45787000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTEX HEALTH INC. · 2023-12-31 NUTEX HEALTH INC. (edgar:1479681) Net Income: -45787000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -45787000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1364711 Filing: 000162828026015168 The citation records this snapshot. The page link may show a newer release later.	USD 1.26 million Exact value Exact value: 1257000 USD 2023-01-01 – 2023-12-31: 1257000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTEX HEALTH INC. · 2023-12-31 NUTEX HEALTH INC. (edgar:1479681) Operating Cash Flow: 1257000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1257000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1285856 Filing: 000162828026015168 The citation records this snapshot. The page link may show a newer release later.	USD 9.5 million Exact value Exact value: 9497000 USD 2023-01-01 – 2023-12-31: 9497000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTEX HEALTH INC. · 2023-12-31 NUTEX HEALTH INC. (edgar:1479681) Capital Expenditure: 9497000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9497000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1289174 Filing: 000162828026015168 The citation records this snapshot. The page link may show a newer release later.	−USD 8.24 million Calculation and evidence 1257000 − 9497000 USD Exact free cash flow: -8240000 USD 2023-01-01 – 2023-12-31: 1257000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 9497000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTEX HEALTH INC. · 2023-12-31 NUTEX HEALTH INC. (edgar:1479681) Free cash flow: -8240000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1257000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1285856 Filing: 000162828026015168 Input fundies:CapitalExpenditure: 9497000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1289174 Filing: 000162828026015168 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	USD 52.1 million Exact value Exact value: 52097000 USD 2024-01-01 – 2024-12-31: 52097000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTEX HEALTH INC. · 2024-12-31 NUTEX HEALTH INC. (edgar:1479681) Net Income: 52097000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: 52097000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1081561 Filing: 000162828026015168 The citation records this snapshot. The page link may show a newer release later.	USD 23.15 million Exact value Exact value: 23153000 USD 2024-01-01 – 2024-12-31: 23153000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTEX HEALTH INC. · 2024-12-31 NUTEX HEALTH INC. (edgar:1479681) Operating Cash Flow: 23153000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 23153000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1285197 Filing: 000162828026015168 The citation records this snapshot. The page link may show a newer release later.	USD 2.3 million Exact value Exact value: 2304000 USD 2024-01-01 – 2024-12-31: 2304000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTEX HEALTH INC. · 2024-12-31 NUTEX HEALTH INC. (edgar:1479681) Capital Expenditure: 2304000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2304000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1288584 Filing: 000162828026015168 The citation records this snapshot. The page link may show a newer release later.	USD 20.85 million Calculation and evidence 23153000 − 2304000 USD Exact free cash flow: 20849000 USD 2024-01-01 – 2024-12-31: 23153000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 2304000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTEX HEALTH INC. · 2024-12-31 NUTEX HEALTH INC. (edgar:1479681) Free cash flow: 20849000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 23153000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1285197 Filing: 000162828026015168 Input fundies:CapitalExpenditure: 2304000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1288584 Filing: 000162828026015168 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	USD 70.79 million Exact value Exact value: 70789000 USD 2025-01-01 – 2025-12-31: 70789000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTEX HEALTH INC. · 2025-12-31 NUTEX HEALTH INC. (edgar:1479681) Net Income: 70789000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: 70789000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1080793 Filing: 000162828026015168 The citation records this snapshot. The page link may show a newer release later.	USD 248.13 million Exact value Exact value: 248125000 USD 2025-01-01 – 2025-12-31: 248125000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTEX HEALTH INC. · 2025-12-31 NUTEX HEALTH INC. (edgar:1479681) Operating Cash Flow: 248125000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 248125000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1284537 Filing: 000162828026015168 The citation records this snapshot. The page link may show a newer release later.	USD 2.53 million Exact value Exact value: 2526000 USD 2025-01-01 – 2025-12-31: 2526000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTEX HEALTH INC. · 2025-12-31 NUTEX HEALTH INC. (edgar:1479681) Capital Expenditure: 2526000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2526000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1287994 Filing: 000162828026015168 The citation records this snapshot. The page link may show a newer release later.	USD 245.6 million Calculation and evidence 248125000 − 2526000 USD Exact free cash flow: 245599000 USD 2025-01-01 – 2025-12-31: 248125000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 2526000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTEX HEALTH INC. · 2025-12-31 NUTEX HEALTH INC. (edgar:1479681) Free cash flow: 245599000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:45:11Z Snapshot: 0f71741f1b503c01b771fcaa9c40ae8b237dd9da639e9e65e1b71d9326abb6e4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1479681?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 248125000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1284537 Filing: 000162828026015168 Input fundies:CapitalExpenditure: 2526000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1479681/000162828026015168/nutx-20251231.htm#1287994 Filing: 000162828026015168 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

88 filings · 5,673 latest values · 5,699 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001479681, 1479681, CLNH, NUTX, edgar:1479681, igam, igmb

Also known as CLINIGENCE HOLDINGS, INC., Clinigence Holdings, Inc, Clinigence Holdings, Inc., NUTEX HEALTH INC., Nutex Health Inc., Nutex Health, Inc., iGambit, Inc.

NUTEX HEALTH INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation